Appearance of islet cell autoantibodies after clinical diagnosis of diabetes mellitus

Autoimmunity

Volumn 29, Issue 1, 1999, Pages 57-63

  Landin Olsson, Mona ^a   Arnqvist, Hans J ^b   Blohmé, Göran ^c   Littorin, Bengt ^d   Lithner, Folke ^e   Nyström, Lennarth ⁱ   Scherstén, Bengt ^f   Sundkvist, Göran ⁱ   Wibell, Lars ^g   Östman, Jan ⁱ   Lernmark, Åke ^h  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d Vastra Faladen Prim Hlth Care Ctr   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f Primary Health Care Centre   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ NONE

Author keywords

Autoimmunity; C peptide; GAD65 antibodies; Islet cell antibodies

Indexed keywords

ANTIBODY; AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADULT; ARTICLE; DIAGNOSIS; DISEASE COURSE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL; SEROCONVERSION;

EID: 0033010230     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939908995973     Document Type: Article

References (31)

1. Landin-Olsson, M., Karlsson, F., Lernmark, Å., Sundkvist, G. and the Diabetes Incidence Study in Sweden Group. Islet cell and thyrogastric antibodies in 633 consequtive 15-34-yr-old patients in the Diabetes Incidence Study in Sweden. Diabetes 1992; 41: 1022-1027.
2. Vanderwalle, C.L., Falorni, A., Svanholm, S., Lernmark, Å., Pipeleers, D.G., Gorus, F.K. and Registry, T.B.D. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J. Clin. Endocrinol. Metab. 1995; 80: 846-851.
3. Hagopian, W.A., Sanjeevi, C.B., Kockum, I., Landin-Olsson, M., Karlsen, A.E., Sundkvist, G., Dahlquist, G., Palmer, J. and Lernmark, Å. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J. Clin. Invest. 1995; 95: 1505-1511.
4. Bingley, P.J., Bonifacio, E., Shattock, M., Gillmor, H.A., Sawtell, P.A., Dunger, D.B., Scott, R.D.M., Bottazzo, G.F. and Gale, E.A.M. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993; 16: 45-50.
5. Bingley, P., Bonifacio, F. and Gale, E.A.M. Can we really predict IDDM? Diabetes 1993; 42: 213-220.
6. Landin-Olsson, M., Karlsson, A., Dahlquist, G., Blom, L., Lernmark, Å. and Sundkvist, G. Islet cell and other organ-specific autoantibodies in all children developing Type I (insulin-independent) diabetes mellitus in Sweden during one year and in matched controls. Diabetologia 1989; 32: 387-395.
7. Riley, W.J., Maclaren, N.K., Krischer, J., Spillar, R.P., Silverstein, J.H., Sehatz, D.A., Schwartz, S., Malone, J., Shah, S., Vadheim, C. and Rotter, J.I. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 1990; 323: 1167-1172.
8. Castano, L. and Eisenbarth, G.S. Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Ann. Rev Immunol. 1990; 8: 647-679.
9. Birk, O.S. and Cohen, I.R. T-cell autoimmunity in type I diabetes mellitus. Curr. Op. Immunol. 1993; 5: 903-909.
10. Roeb, B.O. and Devries, R.R.P. T-lymphocytes and the pathogenesis of type I (insulin-dependent) diabetes mellitus. Eur. J. Clin. Invest. 1992; 22: 697-711.
11. Marner, B., Agner, T., Binder, C. et al. Islet cell antibodies predict loss of fasting C-peptide. Diabetologia 1987; 27: 307A.
12. Gottsäter, A., Landin-Olsson, M., Fernlund, P., Lernmark, Å. and Sundkvist, G. Beta-cell function in relation to islet cell antibodies (ICA) during the first three years after the clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 1993; 16: 902-910.
13. Falorni, A., Grubin, C., Takei, I., Shimada, A., Kasuga, A., Maruyama, T., Ozawa, Y., Kasatani, T., Saruta, T. and Li, L. Radioimmunoassay detects the frequent occurence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-25.
14. Sundkvist, G., Hagopian, W.A., Landin-Olsson, M., Lernmark, Å., Ohlson, F., Erocsson, C. and Ahlmén, J. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1994; 78: 1159-1165.
15. Marner, B., Agner, T., Binder, C. et al. Increased reduction in fasting C-peptide is associated with islet cell antibodies in Type I (insulin-dependent) diabetic patients. Diabetologia 1985; 28: 875-880.
16. Wallensteen, M., Dahlquist, G., Persson, B., Landin-Olsson, M., Lernmark, Å., Sundkvist, G. and Thalme, B. Factors influencing the magnitude, duration, and rate of fall of b-cell function i Type I (insulin-dependent) diabetes children followed for two years from their clinical diagnosis. Diabetologia 1988; 31: 664-669.
17. Östman, J., Lernmark, Å., Landin-Olsson, M., Sundkvist, G., Palmer, J., Arnqvist, H., Blohmé, G., Lithner, F., Littorin, B., Nyström, L., Scherstén, B. and Wibell, L. Autoimmune (Type I) diabetes in young adults in Sweden. Horm. Metab. Res. 1996; 28: 348-350.
18. WHO Study Group. Diabetes mellitus. WHO Technical Report Series 1985; 727.
19. Landin-Olsson, M., Sundkvist, G. and Lernmark, Å. Prolonged incubation on the two-colour immunofluorescent test increases the prevalence and titres of islet cell antibodies in Type I (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-332.
20. Grubin, C., Daniels, T., Tiovola, B., Landin-Olsson, M., Hagopian, W., Li, F., Karlsen, A., Boel, E., Michelsen, B. and Lernmark, Å. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350.
21. Schmidli, R.S., P.G.C., Bonifacio, E. and Participating, L. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 1995; 44: 636-640.
22. Arnqvist, H., Littorin, B., Nyström, L., Scherstén, B., Östman, J., Blohmé, G. and Lithner, F. Difficulties in classifying diabetes at presentation in the young adult. Diab. Med. 1993; 10: 606-613.
23. Marshall, M., Hoyer, P., Petersen, J., Hejnaes, K., Genovese, S., Dyrberg, T. and Bottazzo, G. Contribution of glutamic decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J. Autoimmun. 1994; 7: 497-508.
24. Lernmark, Å., Klöppel, G., Stenger, D., Vathanaprida, C., Fält, K., Landin-Olsson, M., Baskin, D., Palmer, J., Gown, A., Petersen, J., Li. L., Edenvall, H. and Mauseth, R. Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch. 1995; 425: 631-640.
25. Bottazzo, G.F., Dean, B.M., McNally, J.M., MacKay, E.H., Swift, P.G.F. and Gamble, D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N. Engl. J. Med. 1985; 313: 353-360.
26. Foulis, A., McGill, M. and Farquharson, M. Insulitis in type I (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes and interferon-gamma containing cells. J. Pathol. 1991; 165: 97-103.
27. Rother, E., Schochat, T. and Peter, H. Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study. Rheumatol. Int. 1996; 15: 231-237.
28. Svensson, S., Sandler, S. and Sandler, C.H. Lack of long-term beta-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the beta-cells to hyperglycaemia in vivo. J. Endocrinol. 1993; 136: 289-296.
29. Martin, S., Schernthaner, G., Nerup, J., Gries, G.A., Koivisto, V., Dupre, J., Dtrandl, E., Hamet, P., McArthur, R.G., Tan, M.H., Dawson, K., Metha, A., Vanvliet, S., van Graffenried, B., Stiller, C., Kolb, H. and Group CRCT. Follow-up of cyclosporin. A treatment in type I (insulin dependent) diabetes mellitus: lack of long-term effects. Diabetologia 1991; 34: 429-434.
30. Silverstein, J., Maclaren, N., Riley, W., Spillar, R., Radjenovic, D. and Johnson, S. Immunosuppression with azathioprine and prednisolone in recent-onset insulin dependent diabetes mellitus. N. Engl. J. Med. 1988; 319: 599-604.
31. Lampeter, E.F., Tubes, M., Klemens, C., Brocker, U., Friemann, J., Kolb-Bachofen, V., Gries, F.A. and Kolb, H. Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass. Diahetologia 1995; 38: 1397-1404.